Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Operating Leases (2019 - 2025)

Macrogenics (MGNX) has disclosed Operating Leases for 7 consecutive years, with $36.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases rose 12.78% to $36.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.8 million, a 12.78% increase, with the full-year FY2025 number at $36.8 million, up 12.78% from a year prior.
  • Operating Leases was $36.8 million for Q4 2025 at Macrogenics, up from $31.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $36.8 million in Q4 2025 to a low of $17.0 million in Q3 2022.
  • A 5-year average of $27.5 million and a median of $30.0 million in 2022 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: fell 22.81% in 2022, then skyrocketed 77.54% in 2023.
  • Macrogenics' Operating Leases stood at $20.8 million in 2021, then surged by 44.8% to $30.1 million in 2022, then rose by 0.3% to $30.2 million in 2023, then increased by 7.95% to $32.6 million in 2024, then increased by 12.78% to $36.8 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Operating Leases are $36.8 million (Q4 2025), $31.9 million (Q3 2025), and $32.1 million (Q2 2025).